Mansfield AS, Vivien Yin J, Bradbury P, Kwiatkowski DJ, et al. Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma. Lung Cancer 2024;195:107928.
PMID: 39197359